JAK2 and colorectal carcinoma: Activation of the JAK2-STAT3 signaling pathway enhances the viability, clonogenic potential, invasion, and proliferation of CRC cells, including HCT116 and DLD1, thus accelerating CRC progression (Wang et al., 2021).